A Study of CC-99677 in Participants With Active Ankylosing Spondylitis
Status:
Recruiting
Trial end date:
2024-02-14
Target enrollment:
Participant gender:
Summary
This study is designed to learn about response to CC-99677 treatment by measuring signs and
symptoms of Ankylosing Spondylitis (AS), objective measures of disease activity, quality of
life assessments, pharmacokinetics, safety, and tolerability over a 12-week double-blind
period.